Uganda approves twice-yearly HIV Prevention Injection Lenacapavir; It will be available in March
Uganda’s National Drug Authority (NDA) has approved Lenacapavir, a long-acting HIV prevention injection developed by US pharmaceutical company Gilead Sciences, ...








